Search by Drug Name or NDC

    NDC 25021-0701-02 Ketorolac Tromethamine 30 mg/mL Details

    Ketorolac Tromethamine 30 mg/mL

    Ketorolac Tromethamine is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is KETOROLAC TROMETHAMINE.

    Product Information

    NDC 25021-0701
    Product ID 25021-701_ff55e1ab-2a8d-4a56-8b72-5e0a8e00d866
    Associated GPIs 66100037102030 66100037102071
    GCN Sequence Number 039500
    GCN Sequence Number Description ketorolac tromethamine VIAL 30MG/ML(1) INJECTION
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 35239
    HICL Sequence Number 005175
    HICL Sequence Number Description KETOROLAC TROMETHAMINE
    Brand/Generic Generic
    Proprietary Name Ketorolac Tromethamine
    Proprietary Name Suffix n/a
    Non-Proprietary Name ketorolac tromethamine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 30
    Active Ingredient Units mg/mL
    Substance Name KETOROLAC TROMETHAMINE
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204216
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0701-02 (25021070102)

    NDC Package Code 25021-701-02
    Billing NDC 25021070102
    Package 25 VIAL in 1 CARTON (25021-701-02) / 2 mL in 1 VIAL
    Marketing Start Date 2014-09-05
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.76863
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description KETOROLAC 60 MG/2 ML VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis